Blog

Sharing Our Expertise

Reshoring Early-Stage Pharma
The Emergence of a Post COVID-19 Risk Mitigation Strategy Over the last few decades, pharma companies...
Read More >
Semi-Solids: Don’t Underestimate the Potential (or the Challenges)
  For decades, the most popular form of drug dosage has consistently remained oral solids —the...
Read More >
2 Key Factors to Accelerate Drug Approvals: Expertise and Relationships
Drug approvals are often complex and time-consuming, even for generic versions of approved medications....
Read More >
Solid Dosage Formats Remain the Dominant Pharma Trend
Oral solid dosage forms (OSDFs), notably capsules and tablets, continue to be the most popular drug form...
Read More >
LGM Helps Pharma Manage Supply Chain Risks with Added Services Through Nexgen Acquisition
COVID-19 has put supply chain risk management practices under the microscope. Coming on the heels of...
Read More >
Can the U.S. Stop Buying Drugs from China?
The SARS-CoV-2 pandemic has drawn significant attention to just how much US pharmaceutical manufacturers...
Read More >